NCT04233203View on ClinicalTrials.gov

Faster Aspart on Insulin-pump Treated T1DM Patients

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin Faster Aspart

Currently receiving Faster Aspart during 3 or more months.

DEVICE

Insulin pump

Currently receiving CSII therapy during 6 or more months.

Trial Locations (1)

13005

Obispo Rafael Torija, St., Ciudad Real

All Listed Sponsors
collaborator

University of Castilla-La Mancha

OTHER

lead

Jesús Moreno Fernández

OTHER

NCT04233203 - Faster Aspart on Insulin-pump Treated T1DM Patients | Biotech Hunter | Biotech Hunter